Government ❯ Politics ❯ Policy
Pharmaceutical Pricing Drug Pricing Prescription Drug Pricing Nursing Care Reform Affordable Care Act Transgender Rights Drug Pricing Policy Obamacare Prescription Drug Policy Veterans Affairs Medicaid Cuts Transgender Healthcare Biotech Regulation Pharmaceutical Policy Reform Proposals Pharmaceutical Tariffs Medicaid Gender-Affirming Care Medicaid Reform Prescription Drugs Reform Discussions Medicare Policy Long-term Care Insurance Abortion Policy Elder Care Funding Medicare Expansion Reproductive Rights Financing NHS Funding NHS Reform Social Contributions Health Insurance Child Gender Transition NIH Funding In-Vitro Fertilization In Vitro Fertilization Pharmaceutical Benefits Scheme Telehealth Initiatives Drug Price Controls Medical Residency Policy Organ Donation Health Information Technology Medical Franchises Pharmacare Program Abortion Access Aged Care Services Medicaid Initiatives Drug Price Regulation Pharmaceutical Industry Pharmacare Agreements Care Levels Funding Issues Drug Affordability Drug Cost Policy Long-term Care Policy Cancer Research Funding Medical Evacuation Policy International Humanitarian Aid Hospital Funding Medicare Direct Payments Budget Cuts Disability Care Inflation Reduction Act Financial Measures Compensation for Care Workers Health Care Plans BHMS-CCMP Policy Drug Price Negotiation Subsidy Expiration Nursing Home Costs Health Insurance Reform Financial Management Pharmaceutical Regulations Medicare Fraud Pharmacy Management Medicaid Fraud Nursing Care Insurance Reform NHS Regulations Confidential Childbirth Antisemitism Transportation Services Student Support Programs ObamaCare Refunds Home Care Services
Want to see what podcasts are saying about this topic? Search across 165K+ podcasts. Explore Radar
The administration says the policy will cut government drug costs by using international price benchmarks through voluntary deals whose terms remain confidential.
